VitaNova Life Sciences (VNOV) Other financing activities (2017 - 2023)
VitaNova Life Sciences' (VNOV) quarterly Other financing activities came in at $17282.0 in Q3 2023, up 208.61% on a QoQ basis from $5600.0 in Q1 2019.
Powered by 
Analysis
VitaNova Life Sciences (VNOV) Other financing activities (2017 - 2023) Analysis & Trends
VitaNova Life Sciences has disclosed Other financing activities across 4 years of filings, most recently posting $17282.0 for Q3 2023.
- Other financing activities for Q3 2023 came in at $17282.0, changed N/A year-over-year; the trailing twelve-month figure through Apr 2025 was $17282.0 (changed 0.0% YoY), and the FY2024 annual result was $957051.0, changed N/A from the prior year.
- Other financing activities for Q3 2023 stood at $17282.0, up from $5600.0 in the prior quarter.
- Across five years, Other financing activities topped out at $17282.0 in Q3 2023 and bottomed at $5600.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Accenture | 120.96 Bn | 111.91 Bn | 6.13 Bn |
| 2 | UL Solutions | 12.94 Bn | 12.53 Bn | 417.00 Mn |
| 3 | Gartner | 11.74 Bn | 10.25 Bn | 1.19 Bn |
| 4 | Booz Allen Hamilton Holding | 9.28 Bn | 8.74 Bn | 1.46 Bn |
| 5 | Tetra Tech | 9.14 Bn | 8.91 Bn | 243.21 Mn |
| 6 | Genpact | 5.74 Bn | 5.22 Bn | 490.34 Mn |
| 7 | Grand Canyon Education | 3.97 Bn | 3.69 Bn | 204.08 Mn |
| 8 | Fti Consulting | 3.91 Bn | 3.74 Bn | 316.27 Mn |
| 9 | Korn Ferry | 3.90 Bn | 3.09 Bn | 681.29 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.90 Mn | 30,521.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2023 | 17,282.00 |
| Jan 31, 2019 | 5,600.00 |
| Oct 31, 2018 | -5,600.00 |
| Oct 31, 2017 | -6,000.00 |
| Jul 31, 2017 | 5,700.00 |